Murphy & Mullick Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-199
Closed -$1.43K 766
2025
Q4
$1.43K Hold
199
﹤0.01% 629
2025
Q3
$2.13K Sell
199
-10
-5% -$98 ﹤0.01% 592
2025
Q2
$2.03K Hold
209
﹤0.01% 582
2025
Q1
$3.11K Hold
209
﹤0.01% 546
2024
Q4
$3.12K Buy
+209
New +$3.41K ﹤0.01% 536

Other funds holding OGN

Murphy & Mullick Capital Management's OGN Position: Q1 2026 in Review

Murphy & Mullick Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 199 shares — an estimated $1.43K sold.

Murphy & Mullick Capital Management first reported a position in OGN in Q4 2024 and held it in 5 quarters. The position peaked at $3.12K in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Murphy & Mullick Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Murphy & Mullick Capital Management sold 199 Organon & Co shares in Q1 2026, an estimated $1.43K.
  • Murphy & Mullick Capital Management first reported a position in Organon & Co in Q4 2024 and held it in 5 quarters.
  • Murphy & Mullick Capital Management's Organon & Co position peaked at $3.12K in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.